European Commission Slaps AstraZeneca With €60M Fine For Patent Abuse
European antitrust authorities have fined Anglo-Swedish drug maker AstraZeneca PLC €60 million for abusing patent systems to thwart generic competition for the blockbuster ulcer drug Losec....To view the full article, register now.
Already a subscriber? Click here to view full article